Kuo-Cheng Lu
Biochemistry — Taipei Tzu Chi Hospital, Taiwan
kuo-cheng lu
LeadR Profile
Biochemistry
Subspecialties: Nephrology - Nutrition - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 289
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The Circadian-Melatonin Axis in Bone Remodeling: Receptor-Dependent Signaling, Receptor-Independent Actions, and Translational Constraints. osteoblasts, melatonin, bone remodeling, chronotherapy, circadian rhythm, antioxidants, osteoporosis | Biomolecules | 2026 | 0 |
| Molecular Hydrogen and the Uremic Skeleton: A Critical Review and Turnover-State-Dependent Redox Hypothesis in CKD-MBD. osteoblasts, chronic kidney disease-mineral and bone disorder, stress, physiological, oxidative stress, osteoclasts | Antioxidants (Basel) | 2026 | 0 |
| The Calcium-Sensing Receptor in Chronic Kidney Disease-Mineral and Bone Disorder: Structural Biology, Biased Signaling, Osteoimmune Crosstalk, and Therapeutic Implications. parathyroid hormone, kidney diseases, cells, osteoblasts, chronic kidney disease-mineral and bone disorder, homeostasis, receptors, calcium-sensing, kidney, pharmacology, calcium, therapeutics, vascular calcification, osteoclasts, hyperparathyroidism, secondary | Eur J Pharmacol | 2026 | 0 |
| Sjögren's Disease-Associated Renal Tubular Acidosis: An Integrated Immuno-Tubular Model of Tubular Dysfunction. proton-translocating atpases, phenotype, acidosis, renal tubular, therapeutics, acidosis | Int J Med Sci | 2026 | 0 |
| Adynamic Bone Disease in Chronic Kidney Disease: From PTH Suppression-Driven Remodeling Phenotype to Osteoanabolic Therapy. kidney diseases, osteoblasts, bone remodeling, osteogenesis, osteocytes, phenotype, bone diseases, kidney, nephrology, calcium, therapeutics, vascular calcification, bone density, osteoclasts | Am J Nephrol | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Double Blind Placebo Controlled Trial of Eefooton in Patients With Chronic Kidney Disease NCT05227313 — kidney diseases, quality of life, pharmaceutical preparations, dietary supplements, urologic diseases, double-blind method, kidney, solutions, biotechnology, calcium, pharmaceutical solutions, renal insufficiency, renal insufficiency, chronic | N/A | Enrolling by invitation | 2022 |
LeadR Networks
Main global connection map